Stempoint Capital LP

Stempoint Capital LP reported 93 holdings worth US$560M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Stempoint Capital LP reported 93 holdings worth US$560M as of Sep 30, 2026. Largest: Scholar Rock Holding Corporation, Erasca, Inc. and Abivax SA. Filed Nov 16, 2026 (Form 13F).

Holdings
93
Value as reported
US$560M

The filing in full

CompanySharesValue as reported% of portfolio
Scholar Rock Holding Corporation689KUS$33.3M5.9%
Erasca, Inc.2.26MUS$33.1M5.9%
Abivax SA279KUS$27.7M4.9%
Tango Therapeutics, Inc.989KUS$24.7M4.4%
Roivant Sciences Ltd.641KUS$23.5M4.2%
First Tracks Biotherapeutics, Inc.650KUS$23M4.1%
Enliven Therapeutics, Inc.330KUS$15.1M2.7%
Adaptive Biotechnologies Corporation464KUS$13.4M2.4%
Dianthus Therapeutics, Inc.151KUS$13.3M2.4%
Sensei Biotherapeutics, Inc.405KUS$12M2.2%
Spyre Therapeutics, Inc.132KUS$11.8M2.1%
GRAIL, Inc.81,924US$11.5M2.1%
Praxis Precision Medicines, Inc.38,720US$11.3M2.0%
Surrozen, Inc.419KUS$11.1M2.0%
C4 Therapeutics, Inc.3.29MUS$11M2.0%
Aclaris Therapeutics, Inc.2.05MUS$10.8M1.9%
Revolution Medicines, Inc.50,000US$10.3M1.8%
Cytokinetics, Incorporated146KUS$9.61M1.7%
BeOne Medicines Ltd. Class A25,051US$9.17M1.6%
Xenon Pharmaceuticals Inc.222KUS$8.27M1.5%
Johnson & Johnson30,000US$7.94M1.4%
Trevi Therapeutics, Inc.552KUS$7.91M1.4%
Eli Lilly and Company6,599US$7.64M1.4%
Arrowhead Pharmaceuticals, Inc.110KUS$7.19M1.3%
Cerus Corporation2.97MUS$7.06M1.3%
Immunovant, Inc.201KUS$6.8M1.2%
Jade Biosciences, Inc.472KUS$6.63M1.2%
Guardant Health, Inc.33,527US$5.98M1.1%
OmniAb, Inc.1.2MUS$5.97M1.1%
Cogent Biosciences, Inc.184KUS$5.9M1.1%
Biohaven Ltd.397KUS$5.3M0.95%
Mineralys Therapeutics, Inc.200KUS$5.03M0.90%
IDEAYA Biosciences, Inc.124KUS$4.75M0.85%
Celcuity Inc.57,880US$4.6M0.82%
Edgewise Therapeutics, Inc.112KUS$4.53M0.81%
Century Therapeutics, Inc.2.56MUS$4.38M0.78%
Biodesix, Inc.142KUS$4.22M0.75%
BioNTech SE42,200US$4.15M0.74%
Sanofi SA99,880US$4.12M0.74%
Aura Biosciences, Inc.647KUS$4.07M0.73%
CG Oncology, Inc.54,791US$3.88M0.69%
Viridian Therapeutics, Inc.187KUS$3.86M0.69%
Vor Biopharma Inc.201KUS$3.83M0.68%
LB Pharmaceuticals Inc91,757US$3.47M0.62%
Edesa Biotech, Inc.825KUS$3.47M0.62%
Avalyn Pharma Inc.118KUS$3.36M0.60%
Intuitive Surgical, Inc.8,087US$3.29M0.59%
Nurix Therapeutics, Inc.138KUS$3.27M0.58%
Ovid Therapeutics Inc.1.29MUS$3.21M0.57%
Cue Biopharma, Inc.109KUS$2.81M0.50%
United Therapeutics Corporation4,646US$2.52M0.45%
Dyne Therapeutics, Inc.154KUS$2.48M0.44%
Attovia Therapeutics, Inc.138KUS$2.37M0.42%
Oruka Therapeutics, Inc.27,260US$2.27M0.41%
Insmed Incorporated19,603US$2.24M0.40%
GeneDx Holdings Corp.29,275US$2.12M0.38%
Whitehawk Therapeutics, Inc.496KUS$1.86M0.33%
Monopar Therapeutics Inc.23,302US$1.86M0.33%
Helix Acquisition Corp. III172KUS$1.82M0.33%
Arcutis Biotherapeutics, Inc.61,189US$1.62M0.29%
TCGX Acquisition Corp.100KUS$1.25M0.22%
SAB Biotherapeutics, Inc.353KUS$1.12M0.20%
JATT III Acquisition Corp100KUS$1.1M0.20%
Quoin Pharmaceuticals. Ltd236KUS$1.08M0.19%
ADARx Pharmaceuticals, Inc.52,000US$1.04M0.19%
The Oncology Institute, Inc.157KUS$990K0.18%
Cellectar Biosciences, Inc.447KUS$823K0.15%
Alto Neuroscience, Inc.21,763US$556K0.10%
Braveheart Bio, Inc.10,000US$202K0.04%
Relmada Therapeutics, Inc.44,129US$166K0.03%
Vistagen Therapeutics, Inc.338KUS$24,716<0.01%
Solid Biosciences Inc.0US$00.00%
Spruce Biosciences, Inc.0US$00.00%
Tenax Therapeutics, Inc.0US$00.00%
Tyra Biosciences, Inc.0US$00.00%
Zura Bio Limited0US$00.00%
ACADIA Pharmaceuticals Inc.0US$00.00%
Alumis Inc.0US$00.00%
Amylyx Pharmaceuticals, Inc.0US$00.00%
Assembly Biosciences, Inc.0US$00.00%
Axsome Therapeutics, Inc.0US$00.00%
BioAge Labs, Inc.0US$00.00%
CalciMedica, Inc.0US$00.00%
Celldex Therapeutics, Inc.0US$00.00%
Climb Bio, Inc.0US$00.00%
Crescent Biopharma, Inc.0US$00.00%
Damora Therapeutics, Inc.0US$00.00%
Definium Therapeutics, Inc.0US$00.00%
Equillium, Inc.0US$00.00%
EyePoint, Inc.0US$00.00%
Inventiva SA0US$00.00%
Kodiak Sciences Inc0US$00.00%
MapLight Therapeutics, Inc.0US$00.00%
Monte Rosa Therapeutics, Inc.0US$00.00%
Personalis, Inc.0US$00.00%
Protagonist Therapeutics, Inc.0US$00.00%
Rapport Therapeutics, Inc.0US$00.00%
Sionna Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related